Janus Henderson Group
AVXL icon

Janus Henderson Group’s Anavex Life Sciences AVXL Stock Holding History

Janus Henderson Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,000
Closed -$132K – 2414
2025
Q4 		$132K Hold
37,000
– – ﹤0.01% 2385
2025
Q3 		$329K Hold
37,000
– – ﹤0.01% 2170
2025
Q2 		$341K Hold
37,000
– – ﹤0.01% 2119
2025
Q1 		$322K Buy
+37,000
New +$349K ﹤0.01% 2175
2024
Q2 		– Sell
-32,213
Closed -$164K – 2529
2024
Q1 		$164K Buy
32,213
+4
+0% +$23 ﹤0.01% 2457
2023
Q4 		$300K Sell
32,209
-64
-0.2% -$441 ﹤0.01% 2240
2023
Q3 		$212K Buy
32,273
+8
+0% +$64 ﹤0.01% 2355
2023
Q2 		$262K Sell
32,265
-25
-0.1% -$214 ﹤0.01% 2330
2023
Q1 		$277K Buy
32,290
+18,720
+138% +$187K ﹤0.01% 2318
2022
Q4 		$126K Sell
13,570
-13,570
-50% -$145K ﹤0.01% 2290
2022
Q3 		$280K Buy
27,140
+13,593
+100% +$143K ﹤0.01% 2244
2022
Q2 		$136K Sell
13,547
-10
-0.1% -$95 ﹤0.01% 2416
2022
Q1 		$167K Buy
+13,557
New +$167K ﹤0.01% 2483

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group's AVXL Position: Q1 2026 in Review

Janus Henderson Group sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 37,000 shares — an estimated $132K sold.

Janus Henderson Group first reported a position in AVXL in Q1 2022 and held it in 13 quarters. The position peaked at $341K in Q2 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Janus Henderson Group reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Janus Henderson Group sold 37,000 Anavex Life Sciences shares in Q1 2026, an estimated $132K.
  • Janus Henderson Group first reported a position in Anavex Life Sciences in Q1 2022 and held it in 13 quarters.
  • Janus Henderson Group's Anavex Life Sciences position peaked at $341K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.